Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

BARDA Seeks Vaccine Ancillary Materials for Pandemic Preparedness

by Global Biodefense Staff
May 14, 2013

Research on CBRN Medical CountermeasuresThe Department of Health and Human Services (HHS) intends to issue a Request for Proposal (RFP) for ancillary materials such as needles, syringes, combination units and isopropyl alcohol prep pads to meet the vaccine administration needs of the public during a pandemic influenza event.

To ensure coverage, manufacturers are expected to acquire, maintain and rotate inventories of integrated needle and syringe units of various types directed by the Biological Advanced Research and Development Authority (BARDA). The effort seeks to provide long-term solutions that satisfy vaccine administration requirements during pandemic events and account for recent technology advances in vaccine manufacturing where the ability to produce influenza vaccines may outstrip the capability of manufacturers to maintain pace with sufficient syringe units.

Highlighted RFP requirements include the manufacture and purchase availability of up to:

512 million FDA approved integrated needle and syringe combination units
88 million FDA approved needles, safety engineered, of the following sizes: 23Gx1″, 25Gx1″, 25Gx5/8″
88 million FDA approved 3ml Syringes, luer lock, safety engineered
600 million Isopropyl Alcohol Impregnated Prep Pads, sterile, individually sealed, small
300 million FDA approved integrated needle and syringe combination units (conventional)

Supplier must also provide a manufacturing production schedule representative of the surge capacity that can be made available to the USG for pandemic planning purposes. 

The RFP is estimated to be avalabe through FBO.gov on or about May 17, 2013 with proposals being due June 18, 2013.  Multiple awards may result from this solicitation with an estimated award date of around July 2013. Further details are available under Solicitation Number: 13-100-SOL-00015.

Tags: ASPRBARDAHHSInfluenzaPandemicRequest for ProposalsVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Predictive Intelligence for Pandemic Prevention Grant Awarded to Virginia Tech Researchers
Preparedness

Predictive Intelligence for Pandemic Prevention Grant Awarded to Virginia Tech Researchers

October 25, 2022
dressed head to toe in protective suit and gloves, a worker places a dropper of liquid onto a small plastic device to test for Ebola virus
Outbreak News

How Prepared is Uganda for the Current Ebola Outbreak?

September 24, 2022
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC